CRISPR/Cas9-Mediated Genome Editing of Y705 Residue of STAT3 for Genetic Validation of Small Molecule Inhibitors In Breast Cancer Cells​

Authors

Brittany Nicole 'Jesse' Ramirez, University of St. ThomasFollow
Moses Makokha Kasembeli Ph.D., The University of Texas MD Anderson Cancer Center

Files

DOI

-

Program Affiliation

Partnership for Careers in Cancer Science and Medicine Summer Program

Keywords

STAT3, CRISPR, IL-6, Cancer, TTI-101

Recommended Citation

Ramirez, Brittany Nicole 'Jesse' and Kasembeli, Moses Makokha Ph.D., "CRISPR/Cas9-Mediated Genome Editing of Y705 Residue of STAT3 for Genetic Validation of Small Molecule Inhibitors In Breast Cancer Cells​" (2023). 2023 Summer Experience. 112.
doi:-